Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced that an analyst note commenting on the listing of Intercept’s product on the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE